A multimerized form of recombinant human CD40 ligand supports long-term activation and proliferation of B cells

Abstract Background aims CD40-activated B cells have long been studied as potent antigen-presenting cells that can potentially be used for cancer immunotherapy. Nevertheless, their use in human clinical trials has been limited by the lack of a Good Manufacturing Practice–grade soluble human CD40 lig...

Ausführliche Beschreibung